Published On: Wed, Oct 19th, 2016

Imperva, Inc. (NYSE:IMPV) Updated Analyst Coverage


A number of investment brokers have recently updated their price targets on shares of Imperva, Inc. (NYSE:IMPV).

Most recent broker ratings

10/13/2016 – Imperva, Inc. had its “hold” rating reiterated by analysts at Deutsche Bank.

10/06/2016 – Imperva, Inc. was downgraded to “neutral” by analysts at D.A. Davidson. They now have a USD 55 price target on the stock.

10/03/2016 – Imperva, Inc. was downgraded to “neutral” by analysts at BTIG Research.

09/29/2016 – Imperva, Inc. was downgraded to “neutral” by analysts at Buckingham Research.

09/26/2016 – Imperva, Inc. was downgraded to “neutral” by analysts at Nomura. They now have a USD 50 price target on the stock.

09/23/2016 – Imperva, Inc. had its “outperform” rating reiterated by analysts at JMP Securities. They now have a USD 56 price target on the stock.

09/23/2016 – Imperva, Inc. had its “outperform” rating reiterated by analysts at Oppenheimer. They now have a USD 60 price target on the stock.

09/13/2016 – Imperva, Inc. had its “hold” rating reiterated by analysts at Wunderlich. They now have a USD 50 price target on the stock.

08/30/2016 – Imperva, Inc. was downgraded to “sector weight” by analysts at Pacific Crest.

08/08/2016 – Imperva, Inc. had its “outperform” rating reiterated by analysts at Imperial Capital. They now have a USD 50 price target on the stock.

08/05/2016 – Imperva, Inc. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 52 price target on the stock.

08/05/2016 – Imperva, Inc. was upgraded to “buy” by analysts at Needham & Company. They now have a USD 64 price target on the stock.

07/14/2016 – Evercore ISI began new coverage on Imperva, Inc. giving the company a “hold” rating. They now have a USD 45 price target on the stock.

07/08/2016 – Macquarie began new coverage on Imperva, Inc. giving the company a “neutral” rating. They now have a USD 46 price target on the stock.

04/21/2016 – Imperva, Inc. was downgraded to “underweight” by analysts at Morgan Stanley. They now have a USD 36 price target on the stock.

The share price of Imperva, Inc. (NYSE:IMPV) was down -0.53% during the last day of trading, with a day high of 47.55. 931274 shares were traded during the last session.

The stock’s 50 day moving average is 48.32 and its 200 day moving average is 44.74. The stock’s market capitalization is 1.52B. Imperva, Inc. has a 52-week low of 31.11 and a 52-week high of 77.99.

Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises. The Company’s products include its Imperva SecureSphere platform for enterprise data centers, and Imperva Incapsula and Imperva Skyfence offerings for cloud-based security services. Its Imperva SecureSphere platform provides database, file and Web application security across various physical and virtual systems in data centers. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Skyfence product line provides visibility into, and control over, cloud and Software-as-a-Service (SaaS) applications, including shadow information technology (IT).